Belmont, CA, United States of America

John Michael Berry

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 93(Granted Patents)


Location History:

  • Belmont, CA (US) (2007 - 2012)
  • Pacifica, CA (US) (2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by John Michael Berry in Virus Propagation

Introduction

John Michael Berry, an inventive mind residing in Belmont, CA, is recognized for his contributions to the field of virology and vaccine production. With a total of four patents to his name, Berry has significantly influenced the methods of propagating viruses in non-tumorigenic cell lines, enhancing the development of vaccines.

Latest Patents

Among his notable inventions, Berry's latest patent focuses on a non-tumorigenic MDCK cell line designed for the propagation of viruses. This innovative development introduces novel MDCK-derived adherent cell lines that can thrive in both serum-containing and serum-free environments. These cell lines are particularly tailored for producing vaccine materials, especially influenza viruses and ca/ts influenza viruses. The invention not only includes methods and media formulations for maintaining the non-tumorigenic status of MDCK cells but also outlines processes for efficient vaccine material production.

Career Highlights

Berry has a distinguished career associated with leading companies in the pharmaceutical and biotechnology sectors. He has worked with MedImmune Limited and MedImmune Vaccines, Inc., where he has applied his expertise in the development of vaccine technologies. His contributions have enabled advancements in the efficiency of virus propagation, vital for public health.

Collaborations

Throughout his career, Berry has collaborated with various esteemed professionals, including Richard Schwartz and Ajit Subramanian. These partnerships have fostered innovative approaches to vaccine production and research, further solidifying the impact of his work in the field.

Conclusion

In summary, John Michael Berry has made significant strides in the innovation of non-tumorigenic cell lines for virus propagation. His work not only supports the production of crucial vaccines but also demonstrates the importance of collaboration and innovation in advancing scientific research. His contributions are invaluable to the ongoing efforts in public health and virology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…